You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 12, 2025

Profile for Colombia Patent: 6321189


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Colombia Patent: 6321189

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
7,994,185 Jul 20, 2030 Novartis TAFINLAR dabrafenib mesylate
8,415,345 Jul 20, 2030 Novartis TAFINLAR dabrafenib mesylate
9,233,956 Nov 4, 2029 Novartis TAFINLAR dabrafenib mesylate
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Colombia Patent CO6321189

Last updated: July 29, 2025


Introduction

Patent CO6321189 pertains to a pharmaceutical invention filed and granted within Colombia, offering insight into the innovation landscape surrounding relevant drug compositions or methods in the region. This analysis examines the patent’s scope, claims, and placement within the broader patent landscape, fostering an understanding for stakeholders involved in licensing, R&D, or competitive positioning.


Patent Overview and Filing Details

Colombia patent CO6321189 was granted on [insert date], originating from a priority filing in [country or regional office], with primary classifications linked to pharmaceutical compositions and methods. The applicant’s identity, assignee, and inventor details are publicly accessible through the Colombian Superintendency of Industry and Commerce (SIC), revealing strategic interests aligned with specific therapeutic areas.


Scope of the Patent

Claimed Inventions

The core scope of patent CO6321189 covers a specific pharmaceutical composition or method. The claims are designed to delineate the boundaries of exclusion from prior art, often including:

  • Active Ingredient(s): The patent specifies the particular compound(s), their stereochemistry, and form.
  • Formulation Parameters: Dosage forms, excipients, and delivery mechanisms tailored for targeted therapeutic effect.
  • Use or Method Claims: Identifying specific medical uses, indications, or administration methods, expanding utility.

For example, if the patent claims a new combination of active ingredients with synergistic effects for treating a particular disease, it entails protection not only of the compound but also of the therapeutic method.

Claim Structure and Language

Colombian patents follow the Latin American IP Organization (OLADE) and national classifications, with claims structured to encompass:

  • Independent claims: broad coverage of the composition or process.
  • Dependent claims: specific embodiments, such as particular dosage ranges or stability features.

The breadth of claims determines the scope of exclusivity, with narrower claims limiting infringement risks but offering less market exclusivity and vice versa.


Claims Analysis

Scope of Claims

  • Composition Claims: Encompass a pharmaceutical formulation containing specific active compounds with defined ratios, delivery mechanisms, or stability features.
  • Method Claims: Cover treatment methods involving administering the composition, potentially including dosing schedules or patient populations.
  • Use Claims: Protect specific therapeutic uses, such as indications for particular diseases or conditions.

Claim Limitations and Strengths

  • Broad Claims: Offer wider protection, possibly encompassing multiple formulations or methods but risk invalidation if prior art discloses similar compositions.
  • Narrow Claims: More defensible but less commercially expansive, focusing on specific embodiments.

Potential Overlaps and Challenges

  • Overlaps with existing patents could threaten validity; hence, prior art searches are crucial.
  • The scope of claims should balance innovation protection with legal robustness against challenges.

Patent Landscape in Colombia for the Subject Patent

Regional and Global Context

In Colombia, pharmaceutical patent landscape is influenced by international treaties such as TRIPS (Trade-Related Aspects of Intellectual Property Rights) and regional agreements like Andean Community (CAN) patent regulations. The landscape features:

  • Active Patent Families: Drugs benefiting from multiple jurisdictions, with global patent families covering the core innovation to secure broader protection.
  • Patent Clusters: Sometimes, multiple patents in Colombia concerns incremental improvements, such as different formulations, manufacturing processes, or treatment methods.

Major Competitors and Patent Filings

Competitors often file patents similar to CO6321189 relating to formulations, delivery systems, or therapeutic methods. Key considerations include:

  • Patent Overlap and Freedom-to-Operate: Conducting freedom-to-operate analyses to assess potential infringing patents.
  • Patent Publishing Timeline: As Colombian patent applications generally publish after 18 months, understanding the timing of disclosures informs strategic planning.

Legal and Policy Environment

Colombia’s patent laws encourage pharmaceutical innovation but also include provisions for compulsory licensing under certain circumstances, such as public health emergencies, which could affect patent enforcement.

Patent Abandonment and Challenges

Patents in the region face risks from non-renewal or legal challenges. Regular monitoring is essential for maintaining patent scope and enforcement strategies.


Implications for Stakeholders

Pharmaceutical Companies

  • Need to evaluate patent scope carefully to craft licensing or R&D strategies.
  • Understanding the regional landscape helps in designing patent filings to avoid infringement and secure market exclusivity.

Legal Practitioners

  • Must analyze claim language precisely to assess validity and infringement risks.
  • Should monitor patent families worldwide with similar claims.

Policy Makers and Regulators

  • Should consider balancing patent rights and access to medicines, especially in public health contexts.

Key Takeaways

  • Scope & Claims: The Colombian patent CO6321189 likely claims a specific pharmaceutical composition or therapeutic method with defined active ingredients and formulation parameters. The breadth of claims affects enforceability and market exclusivity.
  • Patent Landscape: The patent exists within a competitive regional landscape characterized by overlapping patents and incremental innovations, necessitating vigilant patent monitoring and strategic positioning.
  • Legal Considerations: Patent validity depends on claim novelty and non-obviousness amid existing prior art, with potential challenges from competitors or public health measures.
  • Regional Strategy: Strengthening patent claims through comprehensive international filings and carefully drafted claims enhances protection. Regional legal provisions such as compulsory licensing are considerations for long-term market planning.

FAQs

  1. What are the main components covered by patent CO6321189?
    The patent likely covers specific active pharmaceutical ingredients, formulations, or therapeutic methods aimed at treating particular conditions, with detailed claims outlining these components.

  2. How does Colombia's patent law impact pharmaceutical patent protections like CO6321189?
    Colombian law grants patent protection for novel, inventive pharmaceutical inventions, with certain exceptions. It aligns with TRIPS, offering up to 20 years of exclusivity, but also allows for public health interventions.

  3. What is the significance of claim language in determining patent scope?
    Precise claim language defines the legal boundary of the patent, impacting enforceability and potential infringement. Broad claims provide extensive protection but must be supported by the invention’s inventive step.

  4. How does the patent landscape influence drug commercialization in Colombia?
    Understanding local patent clusters prevents infringement, guides licensing strategies, and influences R&D directions to avoid patent invalidation or litigation.

  5. What strategic considerations should companies have regarding patent CO6321189?
    Companies should conduct thorough freedom-to-operate analyses, consider international patent filings for broader protection, and monitor potential patent challenges or expirations.


Conclusion

The Colombian patent CO6321189 exemplifies regionally tailored pharmaceutical innovation, with scope shaped by specific claims on composition or medical use. Its positioning within the regional patent environment underscores the importance of strategic patent drafting, diligent landscape analysis, and proactive patent management for effective protection and commercialization.


Sources:

  1. Superintendencia de Industria y Comercio (SIC), Colombia.
  2. World Intellectual Property Organization (WIPO).
  3. Andean Community regulations on patents.
  4. TRIPS Agreement.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.